Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

MTI 100 2022: Big Cardio Medtechs Are Moving ESG Agenda To Center Stage

Medtech Insight outlines major trends shaping the top 15 cardiovascular device companies included in the latest Medtech 100 rankings. They include a growing need to reach underserved patient populations, ongoing staffing and other challenges created by the COVID-19 pandemic, and reimbursement obstacles.

Outlook 2022 Cardiology Sustainability

Speaking Of Medtech, Ep. 5: MDUFA V User-Fee Negotiations

In this episode of Speaking Of Medtech we discuss the Medical Device User Fee Amendments, or MDUFA, the negotiations for which come around every five years. The MDUFA V talks between industry and the US FDA appear with the inevitability of an unloved season – it seems no one is ever terribly excited to engage in the user-fee process. Here, we break things down.

User Fees FDA Policy

Exec Chat: Cognetivity’s Simple Brain Test Could Unlock Trillions In Health Care Savings

Cognetivity Neuroscience’s CognICA tool uses a language and education-independent approach to assess whether a patient is exhibiting cognitive decline, so it could also aid drug discovery.

Digital Health Diagnostics Neurology

Stryker Fails To Convince FDA To Exempt Patient-Transport Devices

The US agency didn’t buy Stryker’s argument in its April petition that there is no data suggesting patient-transport devices have a history of false and misleading claims.

FDA Post Market Regulation & Studies Safety

MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other

The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.

Commercial Sales & Earnings Coronavirus COVID-19

Boston Scientific Advances First ‘Modular’ Cardiac Rhythm Management System

The MODULAR ATP clinical trial has begun to enroll patients to evaluate the safety, performance and effectiveness of Boston Scientific’s mCRM modular therapy system, which includes the Emblem MRI S-ICD and the Empower MPS leadless pacemaker.

Research & Development Cardiovascular Clinical Trials

MTI 100 2022: Big Cardio Medtechs Are Moving ESG Agenda To Center Stage

Medtech Insight outlines major trends shaping the top 15 cardiovascular device companies included in the latest Medtech 100 rankings. They include a growing need to reach underserved patient populations, ongoing staffing and other challenges created by the COVID-19 pandemic, and reimbursement obstacles.

Outlook 2022 Cardiology Sustainability

Device Week Podcast


In This Episode:

Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases

Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics. >More Podcasts


Recent Tweets from Medtech Insight

Latest from PR Newswire

Click here to access further medical device and diagnostics news.

Policy & Regulation Explore this Topic

Set Alert for Policy & Regulation

‘A Very Broad Search’: Philips Pushes Back On FDA Claim Of 222,000 Uninvestigated Complaints

Royal Philips says a US FDA investigator wildly overcounted the number of complaints related to recalled breathing machines, disputing an inspection report that says the company failed to investigate hundreds of thousands of complaints. News of the agency’s inspection of a Philips facility – and what might come next for the firm – topped our list of most-read articles in November.

Regulation Policy United States

IVD Regulation Amendment: It’s Now All Down To The European Parliament

The European Council has paved the way for swift adoption of the proposal to amend the IVD Regulation, given the pressures the IVD sector is under. All eyes are now on the European Parliament.

EU Europe Compliance

Latest From Policy & Regulation

Find Resources To Designate IVDR Notified Bodies, Commission Tells Member States

There is growing impetus at the highest EU levels towards ensuring the IVD Regulation is implemented as quickly and effectively as possible. Discussion at the Council of the EU have now added to this drive.

EU Europe

US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs

The agency published minutes from three MDUFA V user fee meetings with medtech industry. The talks include conversations about carryover funds and filling FTEs from past user fee deals.

Regulation Policy

Digital Health Roundup: A Season For Interviews, New Frontiers, AI, Cybersecurity

In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.

Digital Health Companies

Rob Ten Hoedt Reelected Chairman Of MedTech Europe Board

Seven changes have been made to the MedTech Europe board while the tenure of the current chair, a familiar face and well experienced in the role, has been extended for two years.

EU Europe

Biden Announces Insurance Coverage For OTC COVID-19 Tests

The White House also announced it would double commitment it made in September for number of OTC test kits to be distributed free by community groups from 25m kits to 50m and would add rural clinics to the program.

Policy Coronavirus COVID-19

Device Week, 3 December 2021 – What Do The New Eudamed Modules Mean For Medtech?

In this week’s podcast, EU regulatory editor Amanda Maxwell brings listeners up to speed on the latest news from the European Union, including recent module updates and compliance expectations for the Eudamed database.

Device Week EU

Quality Control & Compliance Explore this Topic

Set Alert for Quality Control

Latest From Quality Control

Find Resources To Designate IVDR Notified Bodies, Commission Tells Member States

There is growing impetus at the highest EU levels towards ensuring the IVD Regulation is implemented as quickly and effectively as possible. Discussion at the Council of the EU have now added to this drive.

EU Europe

Device Week, 3 December 2021 – What Do The New Eudamed Modules Mean For Medtech?

In this week’s podcast, EU regulatory editor Amanda Maxwell brings listeners up to speed on the latest news from the European Union, including recent module updates and compliance expectations for the Eudamed database.

Device Week EU

NuVasive Selling Titanium-Based Precice Orthopedic Devices Again, Launches Recall To Update IFU

NuVasive Inc. is marketing its Precice specialized orthopedic devices made of titanium once again after voluntarily pulling them from the market in April over concerns about the safety of the steel-based version of the product. The firm also initiated a recall to address changes in the instructions for use for titanium Precice.

Orthopedics Safety

OUTLOOK 2021

Forward-looking features and special content, including Scrip 100, Medtech 100 and Generics Top 50 industry rankings

VIEW NOW

Commercial Explore this Topic

Set Alert for Commercial

Execs On The Move: Thanksgiving Roundup – Appointments Abound

BD, Baxter, Omron, and Zimmer Biomet are all big names that have appointed new executives in the past two weeks.

Executive Changes Commercial Companies

Latest From Commercial

Digital Health Roundup: A Season For Interviews, New Frontiers, AI, Cybersecurity

In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.

Digital Health Companies

Abbott Claims DexCom CGM Suits Renege On Tech-Sharing Agreement

Abbott says DexCom’s patent suits involve technology that was already the subject of a settlement, and raise venue questions.

Intellectual Property Legal Issues

Bipartisan Bill Seeks To Address US Supply Chain Issues, Prevent Further Crises

Lawmakers have introduced legislation that would establish a national database to help manufacturers expedite the supply chain and avoid further disruptions.

Supply Chain Legislation

NuVasive Selling Titanium-Based Precice Orthopedic Devices Again, Launches Recall To Update IFU

NuVasive Inc. is marketing its Precice specialized orthopedic devices made of titanium once again after voluntarily pulling them from the market in April over concerns about the safety of the steel-based version of the product. The firm also initiated a recall to address changes in the instructions for use for titanium Precice.

Orthopedics Safety

Minute Insight: MeMed Announces Viral/Bacterial Infection Differentiation Results, Commercial Partnership

DiaSorin will distribute MeMed BV, a rapid point-of-care test that can differentiate bacterial and viral infections, under a new commercial agreement.

Clinical Trials In Vitro Diagnostics

I Think, Therefore I Write: Breakthrough Device Turns Thoughts Into Words

Blackrock Neurotech’s MoveAgain technology platform allows patients who have been silenced by ALS, paralysis and other spinal cord injuries the ability to better communicate via text. The device has been granted breakthrough status by the US FDA.

Innovation Neurology

Clinical R&D Explore this Topic

Set Alert for Clinical R&D

Abbott Focuses On Improving Early Diagnosis Of Vascular Disease To Improve Outcomes

Nick West, chief medical officer for Abbott’s vascular business talked to Medtech Insight about Abbott’s efforts to improve the assessment and treatment of vascular disease long before patients need an intervention.

Cardiovascular Artificial Intelligence Diagnostic Imaging

Latest From Research & Development

Minute Insight: Pulsed AF Trial Of Medtronic’s PulseSelect PFA System Completes Enrollment

PULSED AF is a 500-patient pivotal trial of Medtronic’s PulseSelect PFA system for treating both paroxysmal and persistent atrial fibrillation in patients who have not responded to drugs.

Minute Insights Clinical Trials

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

The MITRE corporation and MDIC have produced a manual on how to use cybersecurity threat modeling to make safer medical devices. The document asks four basic questions and provides helpful examples.

Cybersecurity Safety

Minute Insight: FDA Approves First Fluorescent Imaging Agent For Ovarian Cancer

On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.

Minute Insights Cancer

Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care

Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.

Exec Chats Business Strategies

AI Expert: Awareness Is Key To Managing Biases

A Walden University professor discussed various types of biases AI/ML developers need to take into consideration during the recent Xavier Health AI Summit. She noted a working group will produce a white paper laying out different types of biases to raise awareness.

Research & Development Artificial Intelligence

Cala Health Hopes To Jolt Essential Tremor Market With Wrist-Worn Non-Invasive Stimulation

Cala Health’s FDA-cleared Cala Trio wearable for treating essential tremor is currently being tested in Parkinson’s disease patients and is targeting a $20bn global market opportunity.

Start-Up Spotlight Digital Health
UsernamePublicRestriction

Register